Lower Doses of Antibiotics and Shorter Treatment Durations Just As Effective on Children with Pneumonia: Study
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Levaquin, Cipro, Avelox Risks Pose A Concern In Face of Modest Benefits: FDA Reviewers November 4, 2015 Irvin Jackson Add Your Comments Federal drug regulatory officials indicate that the potential side effects of Levaquin, Cipro, Avelox and other fluoroquinolone antibiotics may outweigh the benefits provided by the medications in many cases, as patients often receive the drugs for infections that would typically resolve themselves. In advance of a joint meeting of the agency’s Antimicrobial Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee on Thursday, FDA reviewers released briefing documents that suggest many users may be unnecessarily exposed to a risk of long-term peripheral neuropathy, tendon damage and other problems linked to use of the antibiotics. The two FDA advisory committees are set to discuss the potential fluoroquinolones risks, and make recommendations to the agency about what regulator actions may be necessary to protect consumers. Learn More About Antibiotic Aortic Aneurysm Lawsuits Side Effects of Avelox, Levaquin, Cipro and Other Fluoroquinolone Antibiotics May Cause Peripheral Neuropathy. Lawyers Are Reviewing Lawsuits Nationwide. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Antibiotic Aortic Aneurysm Lawsuits Side Effects of Avelox, Levaquin, Cipro and Other Fluoroquinolone Antibiotics May Cause Peripheral Neuropathy. Lawyers Are Reviewing Lawsuits Nationwide. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The review and the hearing come amid growing concerns over the peripheral neuropathy risks with Levaquin, Avelox and Cipro, potentially leaving users with long-term, debilitating nerve damage While the advisory committees’ recommendations are not binding on the FDA, the agency often factors those recommendations heavily in any regulatory decisions about whether to strengthen label warnings, remove medications from the market or limit use of the drugs. One of the briefing documents provided to the committee members is a review by FDA staffers (PDF) that looked at the benefits and risks of Levaquin and similar fluoroquinolones drugs when used to treat acute bacterial sinusitis (ABS), acute bacterial exacerbation of chronic bronchitis in patients with Chronic Obstructive Pulmonary Disease (ABECB-COPD), and uncomplicated urinary tract infections (UTIs). All of these are common reasons the popular antibiotics are prescribed. Reviewers found that in many cases, the drugs appear to have few benefits, if any. “An evaluation of placebo-controlled trials in ABS or mild ABECB-COPD show that a large proportion of patients randomized to receive placebo recovered and thus these illnesses appear to be self-limited for many patients,” the reviewers noted. “Indeed some of these trials showed no differences in outcome measures when comparing the antibacterial drug to placebo.” The briefing documents do note that there appears to be benefits for patients hospitalized for moderate or severe ABECB-COPD and in the treatment of uncomplicated UTIs. However, they also cautioned doctors to consider the drugs’ risks as well. “When considering the potentially modest treatment benefits of antibacterial drugs for these three indications, the risks of the fluoroquinolone antibacterial drugs should be taken into consideration,” the reviewers warned. “Over the life-cycle of these drugs, several adverse reactions have been reported, and most of them were not evident in the -re-approval safety databases.” The reviewers warned doctors to be concerned about the risks of permanent peripheral neuropathy, tendon ruptures and cardiac arrhythmias, saying that those that resulted in long-term injuries or permanent disability are of “a particular concern.” In its own briefing materials (PDF) provided to the committees, Bayer, the manufacturer of Avelox and Cipro, warned that the infections its drugs were used to treat were not “trivial” and, if left untreated by antibiotics, could result in meningitis, brain abscess and other serious complications. The company noted that the rate of serious side effects raised by reviewers were either rare or very rare. Antibiotic Nerve Damage Risks Levaquin, Avelox and Cipro are among the most widely prescribed antibiotics in the United States, generating billions in annual sales. In 2013, the FDA issued a drug safety communication to announce that it was requiring the manufacturers of Levaquin and other fluoroquinolones to change their warning labels about the risk of peripheral neuropathy problems, providing warnings for the first time that symptoms of nerve damage may continue for months or even years after an individual stops taking the drug. Prior warnings suggested that peripheral neuropathy was a rare risk for users of Levaquin, Avelox and Cipro, and indicated that the problems often resolve once the medications are no longer used. However, many users have been left with a long term and permanent Levaquin neuropathy injury, leading the FDA to require warnings about the permanent nature of the nerve damage in many cases. In 2014, a study published in the medical journal Neurology added further support for these warnings, indicating that side effects of Levaquin and other fluoroquinolones may double the risk of peripheral neuropathy. A growing number of Levaquin lawsuits, Avelox lawsuits and Cipro lawsuits are now being pursued on behalf of users diagnosed with permanent nerve damage, alleging that the antibiotic manufacturers failed to adequately warn consumers and the medical community about the potential long-term risks of peripheral neuropathy. In August, the U.S. Judicial Panel on Multidistrict Litigation (JPML) centralized all of the fluoroquinolone litigation pending throughout the federal court system before U.S. District Judge John R. Tunheim in the U.S. District Court for the District of Minnesota. Given the similar questions of fact and law, the cases have been consolidated for pretrial proceedings to reduce the risk of duplicative discovery into common issues, avoid conflicting pretrial orders from different courts and to serve the convenience of the parties, witnesses and the courts. Tags: Antibiotics, Avelox, Bayer, Cipro, Fluoroquinolone, Johnson & Johnson, Levaquin, Nerve Damage, Peripheral Neuropathy, Tendon Rupture Image Credit: | More Antibiotic Lawsuit Stories New Antiseptic Treatment Could Reduce Antibiotic Use For UTIs: Study March 24, 2022 Lower Doses of Antibiotics and Shorter Treatment Durations Just As Effective on Children with Pneumonia: Study November 30, 2021 Levaquin, Similar Antibiotics May Increase Risk of Cardiac Arrest in Hemodialysis Patients: Study October 26, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025) BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 5 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)
Lower Doses of Antibiotics and Shorter Treatment Durations Just As Effective on Children with Pneumonia: Study November 30, 2021
Levaquin, Similar Antibiotics May Increase Risk of Cardiac Arrest in Hemodialysis Patients: Study October 26, 2021
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 5 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)